GB Sciences' approach to drug discovery combines artificial intelligence and the power of plants to find new treatments based on traditional medicine from around the world. Andrea Small-Howard, its chief science officer and president, said the company is identifying compounds in plants and how the treatments have been used traditionally. "Before computers, drug discovery was done using simplified systems," she said.